Diabetes technology

Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta‐analysis of randomised trials

Diabetes Obes MetabPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

Advancing to higher-level technologies for glucose monitoring and insulin delivery significantly and safely improve glycemic control in older adults with T1D. Physiological age alone should not be a primary barrier to prescribing these technologies, particularly for carefully selected older adults.

Study context

Population
Older adults aged ≥60 years with T1D in randomised controlled trials (RCTs); mean age 69.2 years, mean T1D duration 36.1 years
Participants
482 adults5 RCTs
Comparison
Higher-level vs lower-level diabetes technology
Outcome
Co-primary: TBR <3.9 mmol/L (TBR3.9) and TIR 3.9-10.0 mmol/L
Methodological detailspre-specified domain comparisons (AID vs lower-level insulin delivery; CGM vs SMBG), Three crossover trials contributed to the AID comparison, two parallel trials to the CGM comparison
  • Pre-specified domain comparisons (AID vs lower-level insulin delivery; CGM vs SMBG)
  • Three crossover trials contributed to the AID comparison, two parallel trials to the CGM comparison

Pooled result

As reported in the abstract

Each group vs lower-level technologiesMD (TBR3.9), % (95% CI)P value
Higher-level technologies
−0.62(−1.02 to −0.22)
P = 0.002
Higher-level technologies
MD (TIR) +7.90 % (95% CI 7.09–8.72); P < 0.001

Further pooled results

TBR <3.0 mmol/L, TAR >10.0 and >13.9 mmol/L, HbA1c, glycemic variability

Benefits observed with higher-level technologies (all p <0.05)

Safety

OutcomePeto OR (95% CI)P value
Severe hypoglycaemiaNNT = 200.16 (0.06–0.41)P < 0.001
DKANo significant increase3.72 (0.75–18.49)P = 0.11

Original publication

Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta‐analysis of randomised trials. Diabetes Obes Metab. Published 12 December 2025. doi:10.1111/dom.70355

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.